(1)
Reich, K.; Langley, R. G.; Silvestre, J. F.; Staumont-Salle, D.; Costanzo, A.; Pink, A.; Paller, A.; Katoh, N.; Wollenberg, A.; Warren, R. B.; Øland, C. B.; Tindberg, A.-M.; Gjerum, L.; Simpson, E. Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients With Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials. J of Skin 2024, 8, s375.